Contents:

• Companies involved, and relationships
• Composition, biological and chemical aspects
• Manufacturing methods
• Patents and technology transfer
• Regulatory history and status
• Approved indications
• Market size and share
• Nomenclature
• Controversial aspects, and more!

Coverage:

• Recombinant and other proteins
  
• Antibodies — monoclonal, radioimmune conjugates
  
• Vaccines
  
• Enzymes and toxins
  
• Blood products — human and animal-derived
  
• Cultured cell and tissue products
  
• And other products, e.g., vaccine adjuvants, antisense drugs

New 6th Edition:

• Bigger! 1,602 pages and over 500 monographs and product entries
• New! Bonus Sections — Reviews and analyses of products, FDA approvals and biogenerics (follow-on proteins, biosimilars, etc.)
• Free Web databases — a value-added feature for book owners. Search the product and company databases, then read the full monographs in the book
• Better! Now includes European/EU products;
• Indexes — 32,000+ index entries
• Includes all US, and European products, and many biodefense and biogeneric products
• Includes upcoming products in 2008
• Updated September 2007